AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Viatris (VTRS) shares surged by 5.84% today, marking a significant rebound after the stock price plummeted to a record low earlier in the day, with an intraday decline of 4.35%.
On April 9, 2025, a class action lawsuit was filed against
and certain senior executives, alleging violations of federal securities laws. The lawsuit claims that misled investors about the condition of its manufacturing facilities and the impact of a failed FDA inspection at its Indore, India, facility. The company disclosed on February 27, 2025, that the failed inspection would significantly impact its 2025 revenue and earnings. This led to a substantial drop in Viatris' stock price, falling approximately 15% from $11.24 to $9.53 per share. The lawsuit and the financial repercussions of the FDA inspection are major factors influencing Viatris' stock performance.Knowing stock market today at a glance

Dec.22 2025

Dec.22 2025

Dec.22 2025

Dec.22 2025

Dec.22 2025
Daily stocks & crypto headlines, free to your inbox
What is the current sentiment towards safe-haven assets like gold and silver?
How might the recent executive share sales at Rimini Street impact investor sentiment towards the company?
How could Nvidia's planned shipment of H200 chips to China in early 2026 affect the global semiconductor market?
How should investors position themselves in the face of a potential market correction?
Comments
No comments yet